Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Prednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate and what is the scope of prednisolone acetate patent protection?

Prednisolone acetate
is the generic ingredient in eighteen branded drugs marketed by Allergan, Cent Pharms, Akorn, Bel Mar, Pfizer, Watson Labs, Schering, Taro, Alcon, Novartis Pharms Corp, Pharmafair, Bausch And Lomb, and Novartis, and is included in twenty-seven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Prednisolone acetate has thirty-three patent family members in fourteen countries.

There are eighty-five drug master file entries for prednisolone acetate. Eleven suppliers are listed for this compound.

Summary for Generic Name: prednisolone acetate

Drug Master File Entries: see list85
Suppliers / Packagers: see list11
Bulk Api Vendors: see list40
Clinical Trials: see list550
Patent Applications: see list3,301
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisolone acetate at DailyMed

Pharmacology for Ingredient: prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017468-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
prednisolone acetate; sulfacetamide sodium
SUSPENSION/DROPS;OPHTHALMIC088837-001Dec 24, 1985DISCNNoNo► Subscribe► Subscribe
Novartis Pharms Corp
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017469-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
prednisolone acetate; sulfacetamide sodium
SUSPENSION/DROPS;OPHTHALMIC010210-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
prednisolone acetate
SUSPENSION;ORAL022067-002Jan 17, 2008DISCNNoNo6,071,523► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus